Clinical Trial Update: Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections [Phase 3]

View source ↗

Summary

Phase 3 trial results compare delafloxacin with standard therapy (vancomycin plus aztreonam) for acute bacterial skin and skin structure infections. The study c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin and Skin Structure Infections

Drugs mentioned

• Aztreonam (aztreonam)
• BAXDELA (delafloxacin meglumine)
• Vancomycin (vancomycin)

Snippet

Sponsor: Melinta Therapeutics, Inc. | Conditions: Skin and Subcutaneous Tissue Bacterial Infections, Skin Structures and Soft Tissue Infections | Phase 3 | Status: COMPLETED | Results posted: 2017-08-28